NOS2 and malaria: The pathophysiological impact of NOS2 genetic variance is still not resolved but it should be noted that the NOS2 polymorphisms controlling NO bioavailability in absence of clinical malaria (e.g. rs8078340) are distinct from those associated with alterations of NO bioavailability in overt clinical disease (e.g. rs1800482) (117) (Figure 4).